Benq Medical Technology Stock Total Asset
| 4116 Stock | TWD 48.60 1.05 2.11% |
BenQ Medical Technology fundamentals help investors to digest information that contributes to BenQ Medical's financial success or failures. It also enables traders to predict the movement of BenQ Stock. The fundamental analysis module provides a way to measure BenQ Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BenQ Medical stock.
BenQ |
BenQ Medical Technology Company Total Asset Analysis
BenQ Medical's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current BenQ Medical Total Asset | 1.96 B |
Most of BenQ Medical's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BenQ Medical Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, BenQ Medical Technology has a Total Asset of 1.96 B. This is 74.0% lower than that of the Healthcare sector and 69.05% lower than that of the Medical Devices industry. The total asset for all Taiwan stocks is 93.36% higher than that of the company.
BenQ Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BenQ Medical's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BenQ Medical could also be used in its relative valuation, which is a method of valuing BenQ Medical by comparing valuation metrics of similar companies.BenQ Medical is currently under evaluation in total asset category among its peers.
BenQ Fundamentals
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0386 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 2.97 B | |||
| Shares Outstanding | 44.57 M | |||
| Shares Owned By Insiders | 62.62 % | |||
| Shares Owned By Institutions | 0.05 % | |||
| Price To Earning | 20.45 X | |||
| Price To Book | 2.42 X | |||
| Price To Sales | 1.14 X | |||
| Revenue | 1.46 B | |||
| Gross Profit | 512.28 M | |||
| EBITDA | 166.74 M | |||
| Net Income | 28.84 M | |||
| Cash And Equivalents | 284.61 M | |||
| Cash Per Share | 6.39 X | |||
| Total Debt | 331.25 M | |||
| Debt To Equity | 18.80 % | |||
| Current Ratio | 1.53 X | |||
| Book Value Per Share | 26.36 X | |||
| Cash Flow From Operations | 121.35 M | |||
| Earnings Per Share | 3.78 X | |||
| Number Of Employees | 405 | |||
| Beta | 0.79 | |||
| Market Capitalization | 2.83 B | |||
| Total Asset | 1.96 B | |||
| Z Score | 4.8 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 2.49 % | |||
| Net Asset | 1.96 B | |||
| Last Dividend Paid | 0.5 |
About BenQ Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BenQ Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BenQ Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BenQ Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BenQ Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BenQ Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BenQ Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with BenQ Stock
| 0.76 | 3218 | Universal Vision Bio | PairCorr |
| 0.71 | 4104 | Excelsior Medical | PairCorr |
| 0.82 | 6762 | Delta Asia International | PairCorr |
Moving against BenQ Stock
| 0.61 | 2891B | CTBC Financial Holding | PairCorr |
| 0.59 | 2891 | CTBC Financial Holding | PairCorr |
| 0.47 | 4129 | United Orthopedic | PairCorr |
| 0.44 | 2883 | China Development | PairCorr |
The ability to find closely correlated positions to BenQ Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BenQ Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BenQ Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BenQ Medical Technology to buy it.
The correlation of BenQ Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BenQ Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BenQ Medical Technology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BenQ Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for BenQ Stock Analysis
When running BenQ Medical's price analysis, check to measure BenQ Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BenQ Medical is operating at the current time. Most of BenQ Medical's value examination focuses on studying past and present price action to predict the probability of BenQ Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BenQ Medical's price. Additionally, you may evaluate how the addition of BenQ Medical to your portfolios can decrease your overall portfolio volatility.